U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. CHS Inc./CHS River Plains - 642790 - 08/08/2023
  1. Warning Letters

CLOSEOUT LETTER

CHS Inc./CHS River Plains MARCS-CMS 642790 —

Product:
Animal & Veterinary
Recipient:
Recipient Name
Jay Debertin
Recipient Title
President and CEO
CHS Inc./CHS River Plains

5500 Cenex Drive
Inver Grove Heights, MN 55077
United States

Issuing Office:
Division of Human and Animal Food Operations West I

United States

Dear Mr. Debertin:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter MIN CMS 642790 dated November 30, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Dianna C. Sonnenburg, MPH
Compliance Officer, West Division 1 - CB
Office of Human and Animal Foods Operations

cc: Chad A. VanderLaan
      Location Manager
      CHS River Plains
      998 E. Main Street
      Strasburg, ND 58573-0437

Back to Top